Strides Pharma reports a 17.1% YoY revenue increase in Q2, reaching ₹1,429 crore. Net profit rises 2% amidst stronger growth ...
India's pharmaceutical exports rose 3% to $8.04 billion in Q2 2027-28, driven by strong demand in European markets, ...
Cybersecurity experts emphasize the significance of human oversight in AI-driven security and the critical need for effective ...
Eli Lilly, known for its blockbuster weight-loss and anti-diabetes drugs, is now focusing on neurosciences, with significant ...
In response to safety issues surrounding cough syrups in India, the CDSCO mandates strict monitoring of high-risk solvents ...
Discover how India is addressing cancer drug affordability with a new pricing strategy that aims to lower costs for patients ...
Despite beating quarterly sales and profit expectations, GSK's stock fell due to concerns over its drug pipeline and weak ...
Eli Lilly has announced that its experimental obesity drug, retatrutide, has outperformed Novo's Ozempic in a Phase 3 trial, ...
Piramal Pharma reduces reliance on Chinese raw materials to single-digit levels to enhance supply-chain resilience amid ...
Sandoz, the Swiss generic drugmaker, adjusts its sales growth forecast to 5-6% due to supply constraints, impacting investor confidence and leading to an 8% drop in shares. The company highlights ...
The Indian Patent Office has rejected a patent application for the BPaL regimen, a groundbreaking treatment for ...
Despite a $2.2 billion setback due to failed drug trials, Novartis raises its profit forecast for the year, highlighting ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results